Northwestern Mutual Investment Management Company’s Ligand Pharmaceuticals LGND Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,445	Closed	-$364K	–	902
2021 Q2	$364K	Buy	4,445 +3	+0.1%	+$250	0.01%	866
2021 Q1	$422K	Sell	4,442 -4,423	-50%	-$418K	0.01%	828
2020 Q4	$550K	Sell	8,865 -86	-1%	-$4.9K	0.01%	825
2020 Q3	$625K	Hold	8,951	–	–	0.01%	722
2020 Q2	$625K	Sell	8,951 -247	-3%	-$15.7K	0.01%	724
2020 Q1	$417K	Buy	9,198 +1,156	+14%	+$65.5K	0.01%	758
2019 Q4	$523K	Sell	8,042 -648	-7%	-$43.3K	0.01%	754
2019 Q3	$540K	Sell	8,690 -271	-3%	-$17K	0.01%	715
2019 Q2	$638K	Buy	8,961 +3,131	+54%	+$231K	0.02%	650
2019 Q1	$457K	Sell	5,830 -611	-9%	-$46.3K	0.01%	808
2018 Q4	$545K	Buy	+6,441	New	+$687K	0.01%	758

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Northwestern Mutual Investment Management Company's LGND Position: Q3 2021 in Review

Northwestern Mutual Investment Management Company sold out of Ligand Pharmaceuticals (LGND) in Q3 2021, closing a stake of 4,445 shares — an estimated $364K sold.

Northwestern Mutual Investment Management Company first reported a position in LGND in Q4 2018 and held it in 11 quarters. The position peaked at $638K in Q2 2019. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

Northwestern Mutual Investment Management Company reported no remaining Ligand Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 4,445 Ligand Pharmaceuticals shares in Q3 2021, an estimated $364K.
Northwestern Mutual Investment Management Company first reported a position in Ligand Pharmaceuticals in Q4 2018 and held it in 11 quarters.
Northwestern Mutual Investment Management Company's Ligand Pharmaceuticals position peaked at $638K in Q2 2019.
207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q3 2021, filed 15 Nov 2021.